169 related articles for article (PubMed ID: 17514078)
21. [Case of obsessive-compulsive disorder associated with neuroleptics-induced deficit syndrome (NIDS): successfully treated by discontinuation of neuroleptics followed by SSRI].
Machida N; Shiotsuka S; Semba J
Seishin Shinkeigaku Zasshi; 2005; 107(7):667-73. PubMed ID: 16146185
[TBL] [Abstract][Full Text] [Related]
22. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
23. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
[TBL] [Abstract][Full Text] [Related]
24. Commonly asked questions in the treatment of obsessive-compulsive disorder.
Arumugham SS; Reddy YC
Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
[TBL] [Abstract][Full Text] [Related]
25. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
Cottraux J; Bouvard MA; Milliery M
Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
[TBL] [Abstract][Full Text] [Related]
26. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
[TBL] [Abstract][Full Text] [Related]
27. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
28. Obsessive compulsive disorder: diagnosis and management.
Fenske JN; Schwenk TL
Am Fam Physician; 2009 Aug; 80(3):239-45. PubMed ID: 19621834
[TBL] [Abstract][Full Text] [Related]
29. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
Ressler KJ; Rothbaum BO
JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
[No Abstract] [Full Text] [Related]
30. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.
Conelea CA; Walther MR; Freeman JB; Garcia AM; Sapyta J; Khanna M; Franklin M
J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1308-16. PubMed ID: 25457929
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents.
Masi G; Millepiedi S; Mucci M; Bertini N; Pfanner C; Arcangeli F
Compr Psychiatry; 2006; 47(1):42-7. PubMed ID: 16324901
[TBL] [Abstract][Full Text] [Related]
32. Clinical practice. Obsessive-compulsive disorder.
Jenike MA
N Engl J Med; 2004 Jan; 350(3):259-65. PubMed ID: 14724305
[No Abstract] [Full Text] [Related]
33. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.
Zandberg LJ; Zang Y; McLean CP; Yeh R; Simpson HB; Foa EB
Behav Res Ther; 2015 May; 68():76-81. PubMed ID: 25824533
[TBL] [Abstract][Full Text] [Related]
34. Practice guideline for the treatment of patients with obsessive-compulsive disorder.
Koran LM; Hanna GL; Hollander E; Nestadt G; Simpson HB;
Am J Psychiatry; 2007 Jul; 164(7 Suppl):5-53. PubMed ID: 17849776
[No Abstract] [Full Text] [Related]
35. Obsessive-compulsive disorder and comorbid attention-deficit/hyperactivity disorder: a complex diagnostic disentanglement and treatment.
Pedraza JD; Coffey B
J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):419-22. PubMed ID: 23952190
[No Abstract] [Full Text] [Related]
36. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients.
Storch EA; Bagner DM; Geffken GR; Adkins JW; Murphy TK; Goodman WK
Depress Anxiety; 2007; 24(6):375-81. PubMed ID: 17044015
[TBL] [Abstract][Full Text] [Related]
37. Augmenting treatment of obsessive-compulsive disorder with Antonovsky's sense of coherence theory.
Joachim B; Lyon DD; Farrell SP
Perspect Psychiatr Care; 2003; 39(4):163-8. PubMed ID: 14737822
[TBL] [Abstract][Full Text] [Related]
38. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.
Kochan LD; Qureshi AI; Fallon BA
Curr Psychiatry Rep; 2000 Aug; 2(4):327-34. PubMed ID: 11122977
[TBL] [Abstract][Full Text] [Related]
40. A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.
McGuire JF; Piacentini J; Lewin AB; Brennan EA; Murphy TK; Storch EA
Depress Anxiety; 2015 Aug; 32(8):580-93. PubMed ID: 26130211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
